Literature DB >> 22544165

Living my family's story: identifying the lived experience in healthy women at risk for hereditary breast cancer.

Meghan L Underhill1, Robin M Lally, Marc T Kiviniemi, Christine Murekeyisoni, Suzanne S Dickerson.   

Abstract

BACKGROUND: Based on known or suggested genetic risk factors, a growing number of women now live with knowledge of a potential cancer diagnosis that may never occur. Given this, it is important to understand the meaning of living with high risk for hereditary breast cancer.
OBJECTIVE: The objective of the study was to explore how women at high risk for hereditary breast cancer (1) form self-identity, (2) apply self-care strategies toward risk, and (3) describe the meaning of care through a high-risk breast program.
METHODS: Interpretive hermeneutic phenomenology guided the qualitative research method. Women at high risk for hereditary breast cancer were recruited from a high-risk breast program. Open-ended interview questions focused on experiences living as women managing high risk for breast cancer. Consistent with hermeneutic methodology, the principal investigator led a team to analyze the interview transcripts.
RESULTS: Twenty women participated in in-depth interviews. Analysis revealed that women describe their own identity based on their family story and grieve over actual and potential familial loss. This experience influences self-care strategies, including seeking care from hereditary breast cancer risk experts for early detection and prevention, as well as maintaining a connection for early treatment "when" diagnosis occurs.
CONCLUSIONS: Healthy women living with high risk for hereditary breast cancer are living within the context of their family cancer story, which influences how they define themselves and engage in self-care. IMPLICATIONS FOR PRACTICE: Findings present important practical, research, and policy information regarding health promotion, psychosocial assessment, and support for women living with hereditary breast cancer risk.

Entities:  

Mesh:

Year:  2012        PMID: 22544165      PMCID: PMC3635541          DOI: 10.1097/NCC.0b013e31824530fa

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  42 in total

1.  American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity.

Authors:  Tim Byers; Marion Nestle; Anne McTiernan; Colleen Doyle; Alexis Currie-Williams; Ted Gansler; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Mar-Apr       Impact factor: 508.702

2.  Genomics--the perfect information-seeking research problem.

Authors:  J David Johnson; Donald O Case; James E Andrews; Suzanne L Allard
Journal:  J Health Commun       Date:  2005-06

3.  Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women.

Authors:  S M Lloyd; M Watson; G Oaker; N Sacks; U Querci della Rovere; G Gui
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

4.  Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer.

Authors:  Silvia van Dooren; Caroline Seynaeve; Adriana J Rijnsburger; Hugo J Duivenvoorden; Marie-Louise Essink-Bot; Madeleine M A Tilanus-Linthorst; Jan G M Klijn; Harry J de Koning; Aad Tibben
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

5.  What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group.

Authors:  Sally Tyndel; Joan Austoker; Bethan J Henderson; Kate Brain; Clare Bankhead; Alison Clements; Eila K Watson
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

6.  Cancer genetic predisposition: information needs of patients irrespective of risk level.

Authors:  Alison Metcalfe; Julie Werrett; Lucy Burgess; Cyril Chapman; Collette Clifford
Journal:  Fam Cancer       Date:  2009-06-11       Impact factor: 2.375

7.  Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.

Authors:  Iris van Oostrom; Hanne Meijers-Heijboer; Litanja N Lodder; Hugo J Duivenvoorden; Arthur R van Gool; Caroline Seynaeve; Conny A van der Meer; Jan G M Klijn; Bert N van Geel; Curt W Burger; Juriy W Wladimiroff; Aad Tibben
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

8.  Breast cancer risk perception and lifestyle behaviors among White and Black women with a family history of the disease.

Authors:  Denise Spector; Merle Mishel; Celette Sugg Skinner; Lisa A Deroo; Marcia Vanriper; Dale P Sandler
Journal:  Cancer Nurs       Date:  2009 Jul-Aug       Impact factor: 2.592

9.  Danger zones: risk perceptions of young women from families with hereditary breast and ovarian cancer.

Authors:  Allison V Werner-Lin
Journal:  Fam Process       Date:  2007-09

10.  Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.

Authors:  Yvonne Brandberg; Kerstin Sandelin; Staffan Erikson; Göran Jurell; Annelie Liljegren; Annika Lindblom; Ann Lindén; Anna von Wachenfeldt; Marie Wickman; Brita Arver
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

View more
  9 in total

1.  Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer.

Authors:  Meghan Underhill; Fangxin Hong; Janette Lawrence; Traci Blonquist; Sapna Syngal
Journal:  Psychooncology       Date:  2018-04-19       Impact factor: 3.894

2.  Family Identity and Roles in the Context of Li-Fraumeni Syndrome: "No One's Like Us Mutants".

Authors:  Catherine Wilsnack; Jennifer L Young; Shana L Merrill; Victoria Groner; Jennifer T Loud; Renee C Bremer; Mark H Greene; Payal P Khincha; Allison Werner-Lin
Journal:  Health Soc Work       Date:  2021-11-16

Review 3.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  Influences on Satisfaction with Reconstructed Breasts and Intimacy in Younger Women Following Bilateral Prophylactic Mastectomy: a Qualitative Analysis.

Authors:  Rachael Glassey; Moira O'Connor; Angela Ives; Christobel Saunders; Sarah J Hardcastle
Journal:  Int J Behav Med       Date:  2018-08

5.  Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.

Authors:  Meghan L Underhill; Cheryl B Crotser
Journal:  J Genet Couns       Date:  2013-11-22       Impact factor: 2.537

6.  Patient experiences living with pancreatic cancer risk.

Authors:  Meghan Underhill; Donna Berry; Emily Dalton; Jaclyn Schienda; Sapna Syngal
Journal:  Hered Cancer Clin Pract       Date:  2015-05-21       Impact factor: 2.857

Review 7.  Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.

Authors:  B Meiser; W K T Wong; M Peate; C Julian-Reynier; J Kirk; G Mitchell
Journal:  Hered Cancer Clin Pract       Date:  2017-09-20       Impact factor: 2.857

8.  Awareness of the 2009 US Preventive Services Task Force recommended changes in mammography screening guidelines, accuracy of awareness, sources of knowledge about recommendations, and attitudes about updated screening guidelines in women ages 40-49 and 50+.

Authors:  Marc T Kiviniemi; Jennifer L Hay
Journal:  BMC Public Health       Date:  2012-10-24       Impact factor: 3.295

9.  A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings.

Authors:  Ignaas Devisch; Elfride De Baere; Marlies Saelaert; Heidi Mertes; Tania Moerenhout; Caroline Van Cauwenbergh; Bart P Leroy
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.